PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.68%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-2.25%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-16.28%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-15.24%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-14.95%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-12.50%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-13.75%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.46%
Share reduction while INTC is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.88%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-0.31%
Dividend reduction while INTC stands at 8.38%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-61.75%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-66.59%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
42.07%
10Y revenue/share CAGR under 50% of INTC's 90.01%. Michael Burry would suspect a lasting competitive disadvantage.
2.81%
5Y revenue/share CAGR under 50% of INTC's 23.14%. Michael Burry would suspect a significant competitive gap or product weakness.
14.67%
3Y revenue/share CAGR similar to INTC's 14.13%. Walter Schloss would assume both companies experience comparable short-term cycles.
54.64%
10Y OCF/share CAGR under 50% of INTC's 139.84%. Michael Burry would worry about a persistent underperformance in cash creation.
22.90%
5Y OCF/share CAGR 1.25-1.5x INTC's 16.67%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
67.10%
Positive 3Y OCF/share CAGR while INTC is negative. John Neff might see a big short-term edge in operational efficiency.
91.38%
Similar net income/share CAGR to INTC's 86.92%. Walter Schloss would see parallel tailwinds or expansions for both firms.
23.77%
Positive 5Y CAGR while INTC is negative. John Neff might view this as a strong mid-term relative advantage.
116.01%
3Y net income/share CAGR above 1.5x INTC's 4.84%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
37.06%
Below 50% of INTC's 120.73%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
7.25%
Below 50% of INTC's 49.17%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-1.77%
Negative 3Y equity/share growth while INTC is at 25.21%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
1156.44%
10Y dividend/share CAGR above 1.5x INTC's 160.24%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
190.22%
5Y dividend/share CAGR above 1.5x INTC's 42.64%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
81.56%
3Y dividend/share CAGR above 1.5x INTC's 15.51%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
8.93%
Our AR growth while INTC is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
6.74%
Inventory growth well above INTC's 11.30%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-3.35%
Negative asset growth while INTC invests at 2.33%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-1.19%
We have a declining book value while INTC shows 0.15%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-0.05%
We’re deleveraging while INTC stands at 11.91%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
5.23%
R&D growth drastically higher vs. INTC's 4.07%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
8.89%
SG&A growth well above INTC's 5.10%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.